Torrent Pharmaceuticals (NSE:TORNTPHARM) Scaled Net Operating Assets: N/A (As of Mar. 2026)


NSE:TORNTPHARM Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
85 GF Score
Price ₹4,901.50
GF Value ₹4,359.28
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Torrent Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Torrent Pharmaceuticals's operating assets for the quarter that ended in Mar. 2026 was ₹419,568 Mil. Torrent Pharmaceuticals's operating liabilities for the quarter that ended in Mar. 2026 was ₹117,016 Mil. Torrent Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2025 was ₹0 Mil. Therefore, Torrent Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was N/A.

Torrent Pharmaceuticals Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Torrent Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torrent Pharmaceuticals Scaled Net Operating Assets Chart

Torrent Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.83 0.66 0.67 2.02

Torrent Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:TORNTPHARM vs ZTS, UTHR: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Torrent Pharmaceuticals Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Torrent Pharmaceuticals's Scaled Net Operating Assets falls into.


NSE:TORNTPHARM
85GF Score
Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Torrent Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Torrent Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2026 )
=(Operating Assets (A: Mar. 2026 )-Operating Liabilities (A: Mar. 2026 ))/Total Assets (A: Mar. 2025 )
=(419567.5-117016.3)/149897.4
=2.02

where

Operating Assets(A: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=443119.6 - 23552.1
=419567.5

Operating Liabilities(A: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=267271.3 - 118412.4 - 31842.6
=117016.3

Torrent Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(419567.5-117016.3)/0
=N/A

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=443119.6 - 23552.1
=419567.5

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=267271.3 - 118412.4 - 31842.6
=117016.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued. The current stock price of ₹4,901.50 is trading 12.4% above its estimated GF Value™ of ₹4,359.28. GuruFocus considers Torrent Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for NSE:TORNTPHARM:

  • Scaled Net Operating Assets: N/A
  • GF Value™: ₹4,359.28 vs. price of ₹4,901.50 (12.4% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Torrent Pharmaceuticals Business Description

Other Exchanges 500420:India
Address Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
85GF Score

Get the complete analysis for NSE:TORNTPHARM

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,901.50
Price
₹4,359.28
GF Value